Investigation of Endothelial Cell Density after PreserFlo Implantation Compared to Contralateral Eyes without PreserFlo Implantation – A Retrospective Analysis
Klinische Monatsblätter für Augenheilkunde · 01.04.2025 · 242 (04) · 392-397
DOI: 10.1055/a-2495-8580 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Klinische Monatsblätter für Augenheilkunde, erschienen am 01.04.2025. Verfasst von Ellen Grobshäuser und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ophthalmology, Vista Augenklinik Binningen, Switzerland. Hauptthemen laut MEDLINE: Corneal Endothelial Cell Loss, Glaucoma Drainage Implants, Endothelium, Corneal, Endothelial Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
Background
Loss of corneal endothelial cells after glaucoma surgery can lead to corneal decompensation and reduced vision. This loss may be accelerated by drainage implants like PreserFlo, which allow controlled subconjunctival filtration. In a retrospective analysis, we examined its impact on corneal endothelial cell density (ECD). Patients and methods Data from medical records for 94 eyes were retrospectively analyzed. This included 47 PreserFlo-operated eyes and 47 contralateral control eyes. Inclusion criteria were open-angle glaucoma, laser trabeculoplasty as the only prior glaucoma surgery, and a contralateral control eye without any previous glaucoma surgeries and without any relevant diseases. Only standalone procedures and pseudophakic eyes were considered. We included 48 eyes at 2 weeks (24 operated, 24 control eyes), 72 at 3 months (36 each), 34 at 1 year (17 each), and 36 at 3 years (18 each).
Results
Preoperatively, the 47 eyes that were planned for surgery had a mean ECD of 2141 ± 527 cells/mm², and the 47 control eyes had an ECD of 2114 ± 561 cells/mm². Two weeks postoperatively, ECD decreased by 5.4% in the operated eyes and increased by 1.1% in the control eyes. After 3 months, endothelial cell loss (ECL) was 3.6% (operated) and 1.9% (controls). After 1 year, ECL was 11.7% (operated) and 5.6% (controls); after 3 years it was 7.6% (operated) and 2.9% (controls). No significant differences in ECL dynamics between the operated and control eyes were detected by the analysis of variance.
Conclusion
Although there was a trend to accelerated ECL in operated eyes compared to controls, this difference was not significant. Overall, the Preserflo procedure appears safe as regards to its influence on endothelial cell count.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Ophthalmology, Vista Augenklinik Binningen, Switzerland.
- Ophthalmology Department, University Hospital Basel, Switzerland.
- Ophthalmology, Augenzentrum Bahnhof Basel, Switzerland.
ORCID-Profile: Ellen Grobshäuser, Konstantin Gugleta
Zitieren
APA
Grobshäuser, E., Cunha Vaz Martinho, A., Gatzioufas, Z., Hasler, P., Maloca, P., & Gugleta, K. (2025). Investigation of Endothelial Cell Density after PreserFlo Implantation Compared to Contralateral Eyes without PreserFlo Implantation – A Retrospective Analysis. Klinische Monatsblätter für Augenheilkunde, 242(04), 392-397. https://doi.org/10.1055/a-2495-8580
Vancouver
Grobshäuser E, Cunha Vaz Martinho A, Gatzioufas Z, Hasler P, Maloca P, Gugleta K. Investigation of Endothelial Cell Density after PreserFlo Implantation Compared to Contralateral Eyes without PreserFlo Implantation – A Retrospective Analysis. Klinische Monatsblätter für Augenheilkunde. 2025;242(04):392-397. doi:10.1055/a-2495-8580
BibTeX
@article{Grobshuser2025,
author = {Grobshäuser, Ellen and Cunha Vaz Martinho, Antonio and Gatzioufas, Zisis and Hasler, Pascal and Maloca, Peter and Gugleta, Konstantin},
title = {Investigation of Endothelial Cell Density after PreserFlo Implantation Compared to Contralateral Eyes without PreserFlo Implantation – A Retrospective Analysis},
journal = {Klinische Monatsblätter für Augenheilkunde},
year = {2025},
volume = {242},
number = {04},
pages = {392--397},
doi = {10.1055/a-2495-8580}
}
EUVIMED